|
Session Title |
Type |
Day |
Time |
Room |
|
Understanding the burden of chronic respiratory diseases: what decision makers need to know |
Oral Presentation |
Monday |
08:30 - 10:30 |
Elicium 1 |
|
Mechanisms of acute lung injury and mesenchymal cell treatment |
Oral Presentation |
Monday |
08:30 - 10:30 |
Forum |
|
Clinical application of exhaled biomarkers |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room 5.2 |
|
Molecular pathology and functional genomics of lung disease |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room 3.1 |
|
Cardio-pulmonary interactions |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room 3.2 |
|
Viral respiratory infections in children: causes and consequences |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room 4.2 |
|
Indoor hazards and respiratory disease: irritants and allergens |
Oral Presentation |
Monday |
08:30 - 10:30 |
Emerald |
|
Genes, environment and obstruction |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room D203-204 |
|
Obstructive sleep apnoea: the heart and the brain |
Poster Discussion |
Monday |
08:30 - 10:30 |
Room G102-103 |
|
Comorbidities and impact on society of asthma and COPD |
Poster Discussion |
Monday |
08:30 - 10:30 |
Room G104-105 |
|
Models of disease and drug actions |
Poster Discussion |
Monday |
08:30 - 10:30 |
Room G106-107 |
|
Smoking-related diseases and smoking cessation |
Poster Discussion |
Monday |
08:30 - 10:30 |
Room E104-106 |
|
Tuberculosis: from bench to bedside |
Poster Discussion |
Monday |
08:30 - 10:30 |
Room E102 |
|
T-cell subsets |
Poster Discussion |
Monday |
08:30 - 10:30 |
Room D201-202 |
|
Phenotyping asthma: a clue for treatments? |
Oral Presentation |
Monday |
10:45 - 12:45 |
Elicium 1 |
|
Imaging in COPD |
Oral Presentation |
Monday |
10:45 - 12:45 |
Forum |
|
The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition) |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room 5.2 |
|
What is new in tuberculosis immunodiagnosis? |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room 3.1 |
|
The burden of work-related respiratory disease: known and new end-points |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room 3.2 |
|
Surgery for lung cancer: pre-operative evaluation and results |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room 4.2 |
|
Resuscitation and ventilation in the baby and infant |
Oral Presentation |
Monday |
10:45 - 12:45 |
Emerald |
|
Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room D203-204 |
|
Tuberculosis in immunocompromised hosts |
Poster Discussion |
Monday |
10:45 - 12:45 |
Room G102-103 |
|
Lung cancer: molecular pathology and functional genomics |
Poster Discussion |
Monday |
10:45 - 12:45 |
Room G104-105 |
|
Progress in endoscopy for the diagnosis of lung cancer |
Poster Discussion |
Monday |
10:45 - 12:45 |
Room G106-107 |
|
Mechanical ventilation and lung injury: new advances |
Poster Discussion |
Monday |
10:45 - 12:45 |
Room E104-106 |
|
Genetic and molecular background in pulmonary fibrosis |
Poster Discussion |
Monday |
10:45 - 12:45 |
Room E102 |
|
Advances in lung function testing from infancy to adulthood |
Poster Discussion |
Monday |
10:45 - 12:45 |
Room D201-202 |
|
Acute respiratory failure |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-1 |
|
Intensive care outcome |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-2 |
|
Noninvasive ventilation in the acute setting: education, organisation, H1N1, paediatrics, weaning, diagnostic procedures and special considerations |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-3 |
|
New evidence in home mechanical ventilation |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-4 |
|
Respiratory and skeletal muscle assessment in health and disease |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-5 |
|
Lung and airway function |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-6 |
|
Clinical physiology for clinical problems |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-7 |
|
Innovative methods in exercise testing |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-8 |
|
Epidemiology, diagnosis and treatment in obstructive sleep apnoea |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-9 |
|
Physiology and diagnostic technology in obstructive sleep apnoea |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-10 |
|
Cardiometabolic and neurocognitive changes in obstructive sleep apnoea |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-11 |
|
Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-12 |
|
Obstructive sleep apnoea: clinical aspects I |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-13 |
|
Treatment of human pulmonary hypertension |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-14 |
|
Physiology of human pulmonary hypertension |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-15 |
|
Clinical features of pulmonary hypertension |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-16 |
|
Clinical features of pulmonary thromboembolism |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-17 |
|
Pulmonary hypertension in hypoxic lung disease |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-18 |
|
Treatment of pulmonary hypertension |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-19 |
|
Chest wall trauma and airway management |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-20 |
|
General thoracic surgery I |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-21 |
|
Lung transplantation |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-22 |
|
Aetiology, diagnosis and outcomes in community-acquired pneumonia |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-23 |
|
Assessment of severity and predictors of outcomes in community-acquired pneumonia |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-24 |
|
New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-25 |
|
Infection in the immunocompromised host: infrequent aetiologies |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-26 |
|
Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-27 |
|
Antimicrobial treatment and resistance in lower respiratory tract infections |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-28 |
|
Clinical tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-29 |
|
Management of tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-30 |
|
Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-31 |
|
Tuberculosis epidemiology and public health |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-32 |
|
Risk assessment for tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-33 |
|
Extrapulmonary tuberculosis and surgical interventions |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-34 |
|
Pulmonary and extrapulmonary tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-35 |
|
Clinical challenges in tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-36 |
|
Epidemiology of lung cancer and screening |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-37 |
|
Imaging, functional evaluation and staging for lung cancer patients |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-38 |
|
Palliation and morbidity in lung cancer patients |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-39 |
|
Biomarkers and other new methods for lung cancer |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-40 |
|
Instructive clinical aspects of lung cancer |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-41 |
|
Pleural and mediastinal malignancies: management and rare clinical cases |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-42 |
|
Medical education |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 2-43 |
|
COPD: mechanisms and biomarker |
Oral Presentation |
Monday |
14:45 - 16:45 |
Elicium 1 |
|
Barrier functions in sepsis and acute lung injury |
Oral Presentation |
Monday |
14:45 - 16:45 |
Forum |
|
Treatment options and tumour biology of malignant pleural mesothelioma |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room 5.2 |
|
COPD: burden of disease, imaging and management |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room 3.1 |
|
Comorbidities and management in primary care |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room 3.2 |
|
Noninvasive ventilation on the intensive care unit: from novel application to end of life issues |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room 4.2 |
|
Chest physiotherapy and breathing retraining |
Oral Presentation |
Monday |
14:45 - 16:45 |
Emerald |
|
Novel clinical features of acute and chronic lung diseases |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room D203-204 |
|
Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation |
Poster Discussion |
Monday |
14:45 - 16:45 |
Room G102-103 |
|
Role of infection in exacerbations of COPD |
Poster Discussion |
Monday |
14:45 - 16:45 |
Room G104-105 |
|
Quality control in lung function and exercise-related issues |
Poster Discussion |
Monday |
14:45 - 16:45 |
Room G106-107 |
|
Obstructive sleep apnoea: inflammation and metabolism |
Poster Discussion |
Monday |
14:45 - 16:45 |
Room E104-106 |
|
Improving outcomes after lung transplantation |
Poster Discussion |
Monday |
14:45 - 16:45 |
Room E102 |
|
Epithelial cell biology |
Poster Discussion |
Monday |
14:45 - 16:45 |
Room D201-202 |